A curated bibliography of the scientific, historical, and cultural sources referenced in Soul Search: The Long Walk Home. Organized by chapter.
Ch. 13 — Leaving the Jungle
Des Rochers, K. Oral History of Waimanu Valley. PDF monograph published online circa 1990–1991. Accessed ~2015.
Ch. 15 — Leprechauns in the Insane Asylum
Glore Psychiatric Museum. View source
O'Brien, L. (1967). The magic wisp: A history of the mentally ill in Ireland. Bulletin of the Menninger Clinic, 31(2), 79–95. View source
Ch. 18 — Stripers, Spiders & Shamanism
DEA (2020). Marijuana/Cannabis Drug Fact Sheet. View source
Frame Drums Around the World. View source
Goyal, M., et al. (2014). Meditation programs for psychological stress and well-being. JAMA Internal Medicine.
Hölzel, B. K., et al. (2011). Mindfulness practice leads to increases in regional brain gray matter density. Psychiatry Research.
Marijuana and the Brain. View source
Shamanism in the Celtic World — Order of Bards, Ovates and Druids. View source
Wells, R. E., et al. (2013). Meditation and the default mode network. Wake Forest School of Medicine research.
Ch. 20 — Catholicism, Hallucinogens and Dreamwork
Frontiers in Psychology (2021). View source
Ch. 21 — Frequency, Fire and Trance
Bangor Daily News. (2015). Why the FDA is warning Americans about ibuprofen. View source
CDC Wonder Database — Overdose Statistics. View source
Council on Foreign Relations. Fentanyl and the U.S. Opioid Epidemic. View source
Griffiths, R., et al. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology.
Griffiths, R., et al. (2016). Psilocybin in the treatment of depression and anxiety. Journal of Psychopharmacology, 30(12), 1181–1197.
National Council on Alcoholism and Drug Dependence. View source
National Institute on Drug Abuse — Drug Scheduling Information. View source
NCBI Article. View source
U.S. News & World Report (2022).
Ch. 23 — The Spirit Molecule
Amoroso, T. (2015). The psychopharmacology of MDMA and its role in PTSD treatment. Journal of Psychoactive Drugs, 47(5), 337–344.
Bouso, J. C., et al. (2012). Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca. PLOS ONE.
Da Silveira, D. X., et al. (2005). Ayahuasca in adolescence: A neuropsychological assessment. Journal of Psychoactive Drugs, 37, 129–133.
Doering-Silveira, E., et al. (2005). Ayahuasca in adolescence: A preliminary psychiatric assessment. Journal of Psychoactive Drugs, 37, 123–128.
Dos Santos, R. G., et al. (2016). Antidepressant, anxiolytic and antiaddictive effects of ayahuasca, psilocybin and LSD. Therapeutic Advances in Psychopharmacology, 6(3), 193–213.
Eisner, B. Remembrances of LSD Therapy Past. Annals of Medicine. February 9, 2015.
Grob, C. S., et al. (1996). Human psychopharmacology of hoasca. Journal of Nervous and Mental Disease, 184, 86–94.
Halpern, J. H., et al. (2008). Health and safety in American members of a religion using a hallucinogenic sacrament. Medical Science Monitor, 14, SR15–SR22.
Pollan, M. (2015). The Trip Treatment. The New Yorker. View source
Pollan, M. (2018). How to Change Your Mind. Penguin Press.
Rucker, J. J. H., et al. (2016). Psychedelics in the treatment of unipolar mood disorders. Journal of Psychopharmacology, 30(12), 1220–1229.
Tafur, J. (2017). The Fellowship of the River. Espiritu Books. (Page references to be added.)
Vollenweider, F. X., & Kometer, M. (2010). The neurobiology of psychedelic drugs. Nature Reviews Neuroscience, 11(9), 642–651.
Behind Closed Eyes — Boston University. View source
Ayahuascero vs. Curandero. View source
Ayahuasca Plants and Ingredients. View source
NCBI Research Articles. Source 1 Source 2 Source 3
Low-Dose Repeated Caffeine Administration for Circadian-Phase-Dependent Performance Degradation During Extended Wakefulness. View source
Ch. 24 — Heaven
How We Empathize With Others: A Neurobiological Perspective. View source
Ch. 26 — The Door Left Ajar
Balíková, M. (2002). Collective poisoning with hallucinogenous herbal tea. Forensic Science International, 128(1–2), 50–52.
Riba, J., et al. (2001). Subjective effects and tolerability of ayahuasca in healthy volunteers. Psychopharmacology, 154, 85–95.
Riba, J., et al. (2003). Human pharmacology of ayahuasca. Journal of Pharmacology and Experimental Therapeutics, 306, 73–83.
Ayahuasca: Psychological and Physiologic Effects. View source
Ch. 27 — The Art of Navigation
Pollan, M. (2015). The Trip Treatment. The New Yorker. View source
Chs. 28, 29 & Epilogue
References currently N/A or pending review.
Note on Sources
The reflections in this book arise primarily from lived experience — time spent in wilderness, years of meditation and musical practice, and encounters with altered states of consciousness. Scientific and historical sources were consulted to provide context and to better understand emerging research in neuroscience, psychology, and psychedelic medicine.
The works listed here represent a selection of sources that helped shape the ideas explored in these pages. They are offered as a starting point for readers who wish to explore the scientific and cultural perspectives surrounding these subjects.
Selected Sources
Amoroso, T. (2015). The psychopharmacology of 3,4-methylenedioxymethamphetamine and its role in the treatment of post-traumatic stress disorder. Journal of Psychoactive Drugs, 47(5), 337–344.
Balíková, M. (2002). Collective poisoning with hallucinogenous herbal tea. Forensic Science International, 128(1–2), 50–52.
Bouso, J. C., et al. (2012). Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca: A longitudinal study. PLOS ONE.
Des Rochers, K. Oral History of Waimanu Valley. Online monograph, circa 1990–1991.
Dos Santos, R. G., et al. (2016). Antidepressant, anxiolytic, and anti-addictive effects of ayahuasca, psilocybin, and lysergic acid diethylamide (LSD): A systematic review. Therapeutic Advances in Psychopharmacology, 6(3), 193–213.
Grob, C. S., McKenna, D. J., Callaway, J. C., et al. (1996). Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. Journal of Nervous and Mental Disease, 184, 86–94.
Griffiths, R., et al. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology.
Griffiths, R., et al. (2016). Psilocybin in the treatment of depression and anxiety. Journal of Psychopharmacology, 30(12), 1181–1197.
Halpern, J. H., Sherwood, A. R., Passie, T., Blackwell, K. C., & Ruttenber, A. J. (2008). Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament. Medical Science Monitor, 14, SR15–SR22.
Hölzel, B. K., et al. (2011). Mindfulness practice leads to increases in regional brain gray matter density. Psychiatry Research.
Pollan, M. (2015). The Trip Treatment. The New Yorker. View source
Pollan, M. (2018). How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence. New York: Penguin Press.
Riba, J., et al. (2001). Subjective effects and tolerability of ayahuasca in healthy volunteers. Psychopharmacology, 154, 85–95.
Riba, J., Valle, M., Urbano, G., et al. (2003). Human pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. Journal of Pharmacology and Experimental Therapeutics, 306, 73–83.
Rucker, J. J. H., et al. (2016). Psychedelics in the treatment of unipolar mood disorders: A systematic review. Journal of Psychopharmacology, 30(12), 1220–1229.
Tafur, J. (2017). The Fellowship of the River: A Medical Doctor's Exploration into Traditional Amazonian Plant Medicine. Phoenix, AZ: Espiritu Books.
Vollenweider, F. X., & Kometer, M. (2010). The neurobiology of psychedelic drugs: Implications for the treatment of mood disorders. Nature Reviews Neuroscience, 11(9), 642–651.
Supporting Sources
Bangor Daily News (2015). Why the FDA is warning Americans about ibuprofen. View source
Council on Foreign Relations. Fentanyl and the U.S. Opioid Epidemic. View source
DEA (2020). Marijuana / Cannabis Drug Fact Sheet. View source
Frontiers in Psychology (2021). View source
National Institute on Drug Abuse. View source
NCBI Research Articles. View source
Have a reference you think belongs in the library? Send it via the community page.